GENE.L vs. WRDA.L

Last updated Jun 5, 2026

GENE.L (UBS ETF (IE) Global Gender Equality UCITS ETF (USD) A-acc) and WRDA.L (UBS Core MSCI World UCITS ETF USD Acc) are both Global Equities funds from UBS - GENE.L tracks the MSCI ACWI NR USD while WRDA.L tracks the MSCI World Index. Both are passively managed. Over the past year, GENE.L returned 16.95% vs 27.42% for WRDA.L. A 0.66 correlation means they provide meaningful diversification when combined. GENE.L charges 0.20%/yr vs 0.06%/yr for WRDA.L.

Performance

GENE.L vs. WRDA.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in UBS ETF (IE) Global Gender Equality UCITS ETF (USD) A-acc (GENE.L) and UBS Core MSCI World UCITS ETF USD Acc (WRDA.L). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, GENE.L achieves a 3.70% return, which is significantly lower than WRDA.L's 10.16% return.

GENE.L

• 1D: 0.53%
• 1M: 0.84%
• YTD: 3.70%
• 6M: 6.46%
• 1Y: 16.95%
• 3Y*: 12.36%
• 5Y*: 8.55%
• 10Y*: —

WRDA.L

• 1D: 0.07%
• 1M: 5.13%
• YTD: 10.16%
• 6M: 10.42%
• 1Y: 27.42%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

GENE.L vs. WRDA.L - Yearly Performance Comparison

	2026 (YTD)	2025	2024
GENE.L UBS ETF (IE) Global Gender Equality UCITS ETF (USD) A-acc	3.70%	14.86%	11.69%
WRDA.L UBS Core MSCI World UCITS ETF USD Acc	10.16%	12.77%	20.02%

Correlation

The correlation between GENE.L and WRDA.L is 0.59, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.59
Correlation (All Time) Calculated using the full available price history since Feb 2, 2024	0.66

The correlation between GENE.L and WRDA.L has been stable across timeframes, ranging from 0.59 to 0.66 - a consistent structural relationship.

Return for Risk

GENE.L vs. WRDA.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GENE.L

GENE.L Risk / Return Rank: 48
GENE.L Sharpe Ratio Rank: 47
GENE.L Sortino Ratio Rank: 48
GENE.L Omega Ratio Rank: 45
GENE.L Calmar Ratio Rank: 51
GENE.L Martin Ratio Rank: 51

WRDA.L

WRDA.L Risk / Return Rank: 84
WRDA.L Sharpe Ratio Rank: 84
WRDA.L Sortino Ratio Rank: 84
WRDA.L Omega Ratio Rank: 86
WRDA.L Calmar Ratio Rank: 81
WRDA.L Martin Ratio Rank: 83

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GENE.L vs. WRDA.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for UBS ETF (IE) Global Gender Equality UCITS ETF (USD) A-acc (GENE.L) and UBS Core MSCI World UCITS ETF USD Acc (WRDA.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	GENE.L	WRDA.L	Difference
Sharpe ratio: Return per unit of total volatility	1.61	2.72	-1.12
Sortino ratio: Return per unit of downside risk	2.31	3.72	-1.41
Omega ratio: Gain probability vs. loss probability	1.28	1.52	-0.23
Calmar ratio: Return relative to maximum drawdown	2.49	4.18	-1.69
Martin ratio: Return relative to average drawdown	8.57	16.68	-8.10
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

GENE.L vs. WRDA.L - Sharpe Ratio Comparison

The current GENE.L Sharpe Ratio is 1.61, which is lower than the WRDA.L Sharpe Ratio of 2.72. The chart below compares the historical Sharpe Ratios of GENE.L and WRDA.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	GENE.L	WRDA.L	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.61	2.72	-1.12
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.66	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.67	1.51	-0.84

Drawdowns

GENE.L vs. WRDA.L - Drawdown Comparison

The maximum GENE.L drawdown since its inception was -28.65%, which is greater than WRDA.L's maximum drawdown of -18.38%. Use the drawdown chart below to compare losses from any high point for GENE.L and WRDA.L.

Drawdown Indicators

	GENE.L	WRDA.L	Difference
Max Drawdown Largest peak-to-trough decline	-28.65%	-18.38%	-10.27%
Max Drawdown (1Y) Largest decline over 1 year	-6.79%	-6.53%	-0.26%
Max Drawdown (3Y) Largest decline over 3 years	-15.04%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-15.04%	—	—
Current Drawdown Current decline from peak	-1.85%	-0.12%	-1.73%
Average Drawdown Average peak-to-trough decline	-3.70%	-2.27%	-1.43%
Ulcer Index Depth and duration of drawdowns from previous peaks	1.97%	1.64%	+0.33%

Volatility

GENE.L vs. WRDA.L - Volatility Comparison

UBS ETF (IE) Global Gender Equality UCITS ETF (USD) A-acc (GENE.L) and UBS Core MSCI World UCITS ETF USD Acc (WRDA.L) have volatilities of 2.59% and 2.49%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	GENE.L	WRDA.L	Difference
Volatility (1M) Calculated over the trailing 1-month period	2.59%	2.49%	+0.10%
Volatility (6M) Calculated over the trailing 6-month period	8.14%	7.16%	+0.98%
Volatility (1Y) Calculated over the trailing 1-year period	10.52%	10.03%	+0.49%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	12.96%	12.34%	+0.62%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	14.92%	12.34%	+2.58%

GENE.L vs. WRDA.L - Expense Ratio Comparison

GENE.L has a 0.20% expense ratio, which is higher than WRDA.L's 0.06% expense ratio. However, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.

Dividends

GENE.L vs. WRDA.L - Dividend Comparison

Neither GENE.L nor WRDA.L has paid dividends to shareholders.

Tickers have no history of dividend payments

Frequently Asked Questions

Can I hold both GENE.L and WRDA.L in my portfolio?

GENE.L and WRDA.L have a correlation of 0.59, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, GENE.L or WRDA.L?

On fees, WRDA.L is cheaper at 0.06% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, GENE.L or WRDA.L?

WRDA.L is cheaper with a 0.06% expense ratio, compared with 0.20% for GENE.L.

What is the main difference between GENE.L and WRDA.L?

GENE.L tracks MSCI ACWI NR USD, while WRDA.L tracks MSCI World Index. Their fees differ too: 0.20% for GENE.L and 0.06% for WRDA.L.